Search Results

GPCR Binders, Drugs, and more Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Identification of a potential structure-based GPCR drug for interstitial cystitis/bladder pain syndrome GPCR Events, Meetings, and Webinars 2nd GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem

Binders, Drugs, and more LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine Papers GPCRs: Signal Transduction. GPCR Events, Meetings, and Webinars 2nd GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem

October 2022 Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered activation mechanism "The mechanistic details of the tethered agonist mode of activation for the adhesion GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

September 2022 "G protein‐coupled receptors (GPCRs) are valuable therapeutic targets for many diseases A central question of GPCR drug discovery is to understand what determines the agonism or antagonism small changes to the ligands that invert their pharmacological activity and thus helps to guide the drug This approach can be readily applied to any drug target." Read more at the source #DrGPCR #GPCR #IndustryNews

undrugged peptidergic GPCRs. His presentations will describe Orion’s drug discovery platform, one of the fastest drug discovery solutions in the industry for targeting peptidergic GPCRs. drug candidates." Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Binders, Drugs, and more Altered signaling at the PTH receptor via modified agonist contacts with Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs GPCR Events, Meetings, and Webinars 2nd GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem

October 2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties Read more at the source #DrGPCR #GPCR #IndustryNews

August 2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Summit is totally FREE for our Ecosystem site members? ➡️ https://www.ecosystem.drgpcr.com/ #gpcr #drgpcr

Hi GPCR Enthusiasts (and Arrestin Aficionados!)   This week at Dr. GPCR, we’re decoding arrestin-driven signaling and spotlighting the tools to match.   of GPCR-RAMP discovery. GPCR Updates   Advanced Methods for the Optimization of Candidate Selection  – Master GPCR behavior beyond modules reveal how location bias, intracellular signaling, and ligand kinetics can be leveraged to expand drug

DrGPCR Ecosystem membership or listen wherever you get your podcast for free ➡️https://bit.ly/3UdxgnR #gpcr

Welcome to the 4th official Adhesion GPCR Consortium newsletter! de Investigación y de Estudios Avanzados del IPN (Cinvestav) How did you become involved in adhesion GPCR AB: I became aware of the existence of adhesion GPCRs while completing my graduate studies. The family of adhesion GPCRs called the Latrophilins or ADGRLs first captured my attention due to their AB: The next workshop will likely bring together some of the hottest adhesion GPCR research going on

'unproductive coupling'[1] and a fascinating phenomenon known as GPCR priming [2]. The enhanced signalling observed in GPCR priming is attributed to the formation of temporal non-cognate-GPCR GPCR priming opens new avenues for understanding the nuanced regulatory mechanisms governing GPCR signalling This has significant implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic strategies for modulating GPCR activity.

Think a drug just "locks into" a receptor and does its job? Think again. The Importance of Binding in Drug Action In pharmacology, binding must happen before any drug effect crucial for drug efficacy. It can inform decisions in drug design, improving therapeutic outcomes and reducing unwanted side effects Implications for Drug Development As drug developers, understanding these nuances can significantly impact

to discover new Drugs. Logo Contest: Unleash your creativity and submit your design by August 15th, 2024 Sponsorship Opportunities for arrestin-biased agonism The roles of RGS proteins in cardiometabolic disease GPCR Binders, Drugs in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Research

Enhancing HTRF Assay Performance in GPCR Research Using Fluorescent Ligands GPCRs are involved in numerous physiological processes, making them a key target in drug development.   By using donor-acceptor pairs with different emission spectra that don’t overlap, researchers can design This assay utilized our fluorescent ligand, CELT-335 , designed for hCB 1 /CB 2  cannabinoid receptors power of HTRF and other FRET-based technologies by providing high-performance fluorescent ligands designed

Logo Contest: Unleash your creativity and submit your design by August 15th, 2024 Sponsorship Opportunities translatome via site-selective activation of mTOR GPCR Binders, Drugs, and more Molecular glues as potential heart failure drug following reverse merger with Avrobio Lilly signs $140M upfront partnership with Webinar - The value of GPCR cell-based assays in drug discovery October 2024 | Biologics US 2024 October Director GPCR Drug Discovery Biologist HIGHLIGHT Principal Scientist, In vitro pharmacology Post-Doctoral

cooperative interaction between G βγ subunits and GIRK channels determines both the amplitude and kinetics of GPCR-dependent Read more at the source #DrGPCR #GPCR #IndustryNews

includes congrats to: Ya-Tzu Li for her contributor article titled Do You Believe AI Could Accelerate Drug Logo Contest: Unleash your creativity by designing the event logo! Binders, Drugs, and more Target-based discovery of antagonists of the tick (Rhipicephalus microplus) hunting Role and recent progress of P2Y12 receptor in cancer development Mutation Patterns Predict Drug cell-based assays in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs

GPCR Event Spotlight Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled drug development, incorporating machine learning, innovative biophysical methods, and medicinal chemistry Register today for the GPCR Drug Discovery Conference and save $200 with discount code “ DRGPCR24 ”. - The value of GPCR cell-based assays in drug discovery September 22, 2024 | Biomolecular Horizons 2024 Activation and Signaling Positive allosteric modulation of a GPCR ternary complex GPCR Binders, Drugs

2022 "The very large G protein-coupled receptor (VLGR1, ADGRV1) is the largest member of the adhesion GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

Justin English on "Empowering Drug Discovery for the GPCR Community"! GPCR Consortium: The 11th Adhesion GPCR Workshop. Logo Contest: Showcase your creativity by designing the event logo! drug development GPCRs in Neuroscience Astrocytic PAR1 and mGluR2/3 control synaptic glutamate time GPCR Ecosystem

September 2022 Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative understanding on how endogenous PTHrP transduces signals through its cognate G-protein coupled receptor (GPCR understanding of the biased signaling process of a native protein hormone acting in conjunction with a GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

the regulation of mTORC1 by upstream stimuli, with a specific focus on G-protein coupled receptor (GPCR

drug discovery Nicola J Smith, Lauren T May, and Natasha L Grimsey for their work on Highlights and Binders, Drugs, and more Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid proteomics reveals CLR interactome in primary human cells Exploiting Cell-Based Assays to Accelerate Drug Drug Discovery Engine at ENDO 2024 The Promise of Oxytocin: Novel Approaches for Targeting Oxytocin June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences as a Key to Success in Drug

Get ready for an expedition, GPCR explorers! Welcome back to your weekly GPCR quest! Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, and Drug Discovery Approaches Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory

Watch Episode 167 Today’s GPCR scientists don’t want to study one interaction, they want to model the protein interactions  (e.g., 14-3-3) Heterodimerization Endogenous vs. overexpressed systems Orphan GPCR scientists are already expanding this work, bringing in computational layers  like AlphaFold to model GPCR-RAMP Listen to the complete episode to learn more. _________________ Keyword Cloud : GPCR scientist network , GPCR online course , GPCR data platform , multiplex assays , GPCR drug discovery

GPCR Virtual Cafe is back! Our first guest speaker is none other than Dr. Ben Myers! Learn about communication between GPCRs and PKA, Class F GPCR Smoothened & the Hedgehog signaling pathway https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe

August 2022 "Despite the importance of members of the GPCR superfamily as targets of a broad range of effective medicines many GPCRs remain poorly characterised. pharmacological tool compounds to study its broader role and biology. " Read more at the source #DrGPCR #GPCR

GPCR Symposia Explore GPCRs with our Premium Membership! proteins Identification of Gα12-vs-Gα13-coupling determinants and development of a Gα12/13-coupled designer ADGRG6/GPR126 is a key regulator of receptor signaling GPCR Binders, Drugs, and more Silicon-Rhodamine Drug Discovery Engine at ENDO 2024 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐀𝐋𝐋𝐎𝐃𝐃: 𝐀𝐥𝐥𝐨𝐬𝐭𝐞𝐫𝐲 𝐢𝐧 𝐃𝐫𝐮𝐠 June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences as a Key to Success in Drug